Orexin modulation of stress reactivity as a novel targeted treatment for anxiety and alcohol use disorder

Neuropsychopharmacology. 2022 Jan;47(1):397-398. doi: 10.1038/s41386-021-01120-4.

Authors

Stephanie M Gorka^{1

2}, K Luan Phan³

Affiliations

¹ Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH, USA. Stephanie.Gorka@osumc.edu.
² Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA. Stephanie.Gorka@osumc.edu.
³ Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH, USA.

No abstract available

Publication types

News
Research Support, N.I.H., Extramural

MeSH terms

Alcoholism* / drug therapy
Anxiety / drug therapy
Anxiety Disorders / drug therapy
Humans
Orexin Receptor Antagonists
Orexin Receptors
Orexins

Substances

Orexin Receptor Antagonists
Orexin Receptors
Orexins

Grants and funding